We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.06B
AUM Growth
-$221M
Cap. Flow
-$22.1M
Cap. Flow %
-1.07%
Top 10 Hldgs %
18.33%
Holding
249
New
38
Increased
87
Reduced
99
Closed
17

Top Buys

Rank Stock Value
1
AIR icon
AAR Corp
AIR
+$23.4M
2
RDNT icon
RadNet
RDNT
+$13.8M
3
IMGN
Immunogen Inc
IMGN
+$13.8M
4
CBAY
Cymabay Therapeutics
CBAY
+$13M
5
SVV icon
Savers
SVV
+$12.6M

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$32.3M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$27.5M
3
PLNT icon
Planet Fitness
PLNT
+$27.5M
4
SMCI icon
Super Micro Computer
SMCI
+$17.1M
5
WOOF icon
Petco
WOOF
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 27.32%
2 Industrials 21.96%
3 Technology 19.12%
4 Consumer Discretionary 9.24%
5 Financials 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HES
151
DELISTED
Hess
HES
$836K 0.04%
5,467
-116
-2% -$17.5K
PINS icon
152
Pinterest
PINS
$12.4B
$836K 0.04%
+30,913
New +$844K
SGEN
153
DELISTED
Seagen Inc. Common Stock
SGEN
$819K 0.04%
3,859
+2,371
+159% +$474K
LPLA icon
154
LPL Financial
LPLA
$26.3B
$794K 0.04%
+3,339
New +$775K
VEEV icon
155
Veeva Systems
VEEV
$30.3B
$762K 0.04%
3,745
-78
-2% -$15.7K
ABT icon
156
Abbott
ABT
$180B
$736K 0.04%
7,598
– –
COST icon
157
Costco
COST
$415B
$734K 0.04%
1,300
– –
HAL icon
158
Halliburton
HAL
$27.9B
$713K 0.03%
17,615
-4,773
-21% -$187K
TEVA icon
159
Teva Pharmaceuticals
TEVA
$35.9B
$688K 0.03%
+67,452
New +$628K
LHX icon
160
L3Harris
LHX
$55.9B
$672K 0.03%
3,858
+407
+12% +$74.9K
TREX icon
161
Trex
TREX
$4.51B
$632K 0.03%
10,262
+173
+2% +$11.9K
KEYS icon
162
Keysight
KEYS
$54.5B
$579K 0.03%
4,376
-93
-2% -$13.8K
NVST icon
163
Envista
NVST
$4.28B
$572K 0.03%
20,515
-453
-2% -$14.7K
MSCI icon
164
MSCI
MSCI
$40B
$558K 0.03%
+1,088
New +$572K
REGN icon
165
Regeneron Pharmaceuticals
REGN
$68.8B
$557K 0.03%
677
+272
+67% +$214K
TTD icon
166
Trade Desk
TTD
$8.13B
$556K 0.03%
7,116
+2,063
+41% +$167K
SCHW
167
Charles Schwab
SCHW
$177B
$546K 0.03%
9,941
-4,627
-32% -$280K
ALNY icon
168
Alnylam Pharmaceuticals
ALNY
$36.3B
$535K 0.03%
3,019
-67
-2% -$12.8K
APH icon
169
Amphenol
APH
$188B
$530K 0.03%
12,618
-276
-2% -$11.9K
NFE icon
170
New Fortress Energy
NFE
$101M
$501K 0.02%
15,278
-336
-2% -$9.88K
MTD icon
171
Mettler-Toledo International
MTD
$26.8B
$475K 0.02%
429
+213
+99% +$261K
TRMB icon
172
Trimble
TRMB
$12.3B
$470K 0.02%
8,726
-188
-2% -$9.96K
RMD icon
173
ResMed
RMD
$28.3B
$466K 0.02%
3,151
+688
+28% +$124K
FTI icon
174
TechnipFMC
FTI
$30.6B
$439K 0.02%
21,587
-17,621
-45% -$333K
ICLR icon
175
Icon
ICLR
$12.8B
$437K 0.02%
+1,776
New +$448K
5 6
7
8 9

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Emerald Advisers held 249 positions worth $2.06B, down 9.7% from $2.29B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q3 2023 filing shows 38 new, 87 increased, 99 reduced and 17 closed positions. Its largest new stake was RadNet: 443,538 shares worth $12.5M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $32.3M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.

  • Emerald Advisers's largest Q3 2023 buy was RadNet: 443,538 shares worth $12.5M.
  • Emerald Advisers added most to AAR Corp in Q3 2023, an estimated $23.4M increase.
  • Emerald Advisers's biggest Q3 2023 reduction was Super Micro Computer, cutting an estimated $17.1M.
  • Emerald Advisers fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $32.3M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.06B portfolio in Q3 2023.
  • Emerald Advisers opened 38 new positions and closed 17 in Q3 2023.
  • Emerald Advisers's portfolio value fell 9.7% quarter-over-quarter to $2.06B.

Based on Emerald Advisers's 13F filing for Q3 2023, filed 26 Oct 2023.